| 发明名称 | Delphinidin for combating melanoma cells | ||
| 摘要 | The invention relates to a composition comprising: a complex of delphinidin and a sulfoalkyl ether-β-cyclodextrin and/or delphinidin and the salts thereof as a first component; and a tumour-necrosis factor related apoptosis-inducing ligand (TRAIL) as a second component, for use in the treatment of malignant melanoma. | ||
| 申请公布号 | US9511047(B2) | 申请公布日期 | 2016.12.06 |
| 申请号 | US201314651264 | 申请日期 | 2013.11.28 |
| 申请人 | SAPIOTEC GMBH | 发明人 | Roewer Norbert;Broscheit Jens |
| 分类号 | A61K31/54;A61K38/21;A61K31/352;A61K38/19;A61K45/06;A61K38/17;A61K31/7042;A61K47/48;B82Y5/00 | 主分类号 | A61K31/54 |
| 代理机构 | Casimir Jones, S.C. | 代理人 | Casimir Jones, S.C. ;Brow Mary Ann |
| 主权项 | 1. A composition comprising: as a first component a complex of delphinidin and a sulfoalkyl ether β-cyclodextrin and/ordelphinidin or salts thereof and as second componenta Tumor necrosis factor-Related Apoptosis-Inducing Ligand (TRAIL) for use in the treatment of malignant melanoma. | ||
| 地址 | Wurzburg DE | ||